A recent clinical trial published in the New England Journal of Medicine found that patients with type 2 diabetes using an automated insulin delivery (AID) system achieved a greater reduction in glucose levels than those receiving traditional care. The trial involved 319 adult patients treated with insulin across multiple U.S. and Canadian sites. AID systems, which adjust insulin delivery based on real-time glucose monitoring, are known to be beneficial for type 1 diabetes, but their impact on type 2 diabetes had not been well-studied until now.
Patients with type 2 diabetes treated with automated insulin delivery significantly reduced glucose levels compared to those receiving usual care, highlighting the AID system's effectiveness.
AID systems, known as insulin pumps, have demonstrated a clear advantage by automatically adjusting insulin delivery based on continuous glucose monitoring, benefiting patients significantly.
#type-2-diabetes #automated-insulin-delivery #clinical-trial #continuous-glucose-monitoring #insulin-pumps
Collection
[
|
...
]